HLA Class II Alleles and the Presence of Circulating Epstein-Barr Virus DNA in Greek Patients with Nasopharyngeal Carcinoma
✍ Scribed by Charisios Karanikiotis; Michail Daniilidis; Nikolaos Karyotis; Charalambos Bakogiannis; Theofanis Economopoulos; Samuel Murray; Demetris Papamichael; Epaminondas Samantas; Angelos Nikolaou; Lemonia Skoura; Nikolaos Tselis; Nikolaos Zamboglou; George Fountzilas
- Publisher
- Springer
- Year
- 2008
- Tongue
- German
- Weight
- 261 KB
- Volume
- 184
- Category
- Article
- ISSN
- 0179-7158
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
A salt-dependent DNA polymerase activity was demonstrated in the culture of an EBV-producing, lymphoblastoid cell line (NPC-204 cells) treated with 5-iodo-2'-deoxyuridine (IUdR). There was a high frequency of levels of antibody to this enzyme in sera of patients with nasopharyngeal carcinoma (NPC).
## Abstract Biopsy specimens from Alaskan Native patients with nasopharyngeal carcinoma (NPC) and from other patients seen on the otolaryngology service were tested for Epstein‐Barr virus‐specific DNA and nuclear antigen (EBNA). Serum samples from both groups were tested for various EBV‐related ant
## Abstract ## BACKGROUND Patients with International Union Against Cancer (UICC) Stage I–II nasopharyngeal carcinoma (NPC) appear to have a relatively favorable prognosis and generally are excluded from trials of combined modality treatment. More recently, plasma/serum cell‐free Epstein‐Barr viru
The Epstein-Barr virus (EBV) is a ubiquitous Herpes virus which causes infectious mononucleosis and is associated with such different neoplasms as Burkitt's lymphoma and nasopharyngeal carcinoma. EBV latently infects its target cells; nevertheless, evidence of viral replication in NPC tumours has be